Key result
ShenZhuGuanXin granules dose-dependently reduce infarct size in MI rats by upregulating PECAM-1 and VEGF.
RCT
randomly divided
ShenZhuGuanXin granules dose-dependently improved cardiac function and reduced infarct size in a rat model of myocardial infarction by promoting angiogenesis.
Should not change MI practice; leaves open translation of angiogenesis benefits from rat models to humans.
BACKGROUND: Myocardial infarction (MI) is the main cause of global mortality and morbidity despite the development of therapeutic approaches. ShenZhuGuanXin granules (SG) have been shown to possess cardioprotective effects against coronary heart disease (CHD). However, little is known about its specific mechanism. The present study aimed to investigate the therapeutic effect of SG in cardiac dysfunction and to demonstrate whether SG can promote myocardium angiogenesis by establishing a rat model of myocardial infarction with left anterior descending ligating. METHODS AND RESULTS: Three days after MI, rats were randomly divided into six groups: sham group (sham), MI group (MI), MI + low dose SG (SG-L) group, MI + middle dose SG (SG-M) group, MI + high dose SG (SG-H) group, and MI + compound Danshen dropping pills (CDDP) group as a positive control. Four weeks after administration, rats underwent hemodynamics and echocardiography study. Ventricle tissues were processed for histology and immunohistochemistry studies. Compared with MI group, SG treatment dose-dependently improved cardiac hemodynamic function, attenuated infarct size, increased microvessel density, and increased the expression of PECAM-1/CD31 and VEGF. CONCLUSIONS: SG dose-dependently improved cardiac hemodynamic function and attenuated infarct size by promoting angiogenesis through upregulating PECAM-1/CD31 and VEGF expression.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2017) conducted an RCT in Myocardial infarction. ShenZhuGuanXin granules (SG) vs. sham, MI alone, and compound Danshen dropping pills (CDDP) was evaluated on cardiac hemodynamic function, infarct size, microvessel density, and PECAM-1/CD31 and VEGF expression. ShenZhuGuanXin granules dose-dependently improved cardiac hemodynamic function and attenuated infarct size in myocardial infarction rats by upregulating PECAM-1/CD31 and VEGF expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: